DOPAMINE HYDROCHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for dopamine hydrochloride and what is the scope of patent protection?

Dopamine hydrochloride is the generic ingredient in six branded drugs marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for dopamine hydrochloride. Seven suppliers are listed for this compound.

Summary for DOPAMINE HYDROCHLORIDE

US Patents:	0
Tradenames:	6
Applicants:	14
NDAs:	37
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	108
Clinical Trials:	1,003
Patent Applications:	3,336
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in DOPAMINE HYDROCHLORIDE?	DOPAMINE HYDROCHLORIDE excipients list
DailyMed Link:	DOPAMINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for DOPAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Yantai University	Phase 4
Sir Run Run Shaw Hospital	N/A
Texas Tech University Health Sciences Center, El Paso	Early Phase 1

See all DOPAMINE HYDROCHLORIDE clinical trials

Pharmacology for DOPAMINE HYDROCHLORIDE

Drug Class	Catecholamine

Medical Subject Heading (MeSH) Categories for DOPAMINE HYDROCHLORIDE

Cardiotonic Agents
Dopamine Agents
Sympathomimetics

Anatomical Therapeutic Chemical (ATC) Classes for DOPAMINE HYDROCHLORIDE

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for DOPAMINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	INTROPIN	dopamine hydrochloride	INJECTABLE;INJECTION	017395-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbott	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	070657-001	Jan 24, 1989		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Parenteral	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	072999-001	Oct 23, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.